Keywords: acelrx, oral, sufentanilin, shows, strong, ph, ii

AcelRx' oral sufentanilin shows strong Ph II results

Article | 15 December 2008

AcelRx Pharmaceuticals, a privately-held US pharmaceutical company dedicated to the development and commercialization of new therapies for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in